Canvas Medical vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
Modern cloud-native EHR for direct primary care and value-based care organizations; API-first architecture replacing legacy systems competing with athenahealth and Elation Health.
About
Canvas Medical is a cloud-native electronic health record (EHR) platform designed specifically for modern primary care practices — combining clinical documentation (notes, orders, prescriptions), care management (population health tracking, chronic disease programs, care gap identification), billing and revenue cycle, and patient communication in an integrated system built on a contemporary technical architecture. Founded in 2015 in San Francisco, Canvas Medical targets independent primary care practices, direct primary care (DPC) practices, and value-based care organizations frustrated with legacy EHR systems.\n\nCanvas Medical's technical approach differs from legacy EHRs (Epic, athenahealth, eClinicalWorks) which were built in the early 2000s — Canvas uses a modern, API-first architecture that makes integration with third-party tools straightforward, and its workflow design reflects current clinical practice patterns rather than 1990s paper-chart workflows. The platform is particularly popular with DPC (direct primary care) practices that operate on membership subscription models, where the EHR needs to support high-touch patient communication and proactive care rather than just fee-for-service billing. Canvas also serves value-based care organizations where population health management tools matter.\n\nIn 2025, Canvas Medical competes with athenahealth, Modernizing Medicine, Elation Health, and DrChrono for ambulatory EHR market share in the primary care segment. The EHR market is mature but experiencing disruption pressure as smaller, newer entrants offer more modern experiences to independent practices that Legacy systems with dated UX can't match. The Canvas SDK allows developers to build custom workflow integrations, positioning Canvas as a platform rather than a closed system. The 2025 strategy focuses on growing with DSC and value-based care organizations scaling their primary care networks, deepening AI-powered clinical documentation (ambient note generation), and expanding the developer ecosystem built on Canvas's open API.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.